The Panel Members

Mr. Paul CHAU – Chairperson
Head of Investment Banking & Global Capital Markets
Ping An of China Capital (Hong Kong) Co. Limited

Prof. Ka Leung Francis CHAN
Dean, Faculty of Medicine
Director, Centre for Gut Microbiota Research
Choh-Ming Li Professor of Medicine & Therapeutics,
The Chinese University of Hong Kong

Mr. Hardy CHAN
Chairman, Helios BioElectronics Inc, and Nano Targeting & Therapy Biopharma Inc.

Mr. Ronald CHAN
Founder & Chief Investment Officer, Chartwell Capital

Mr. Bong CHAN
Leader of SR CBD and SR TMT, Deloitte China

Mr. Charles CHAU
Partner, Jones Day

Prof. Hao CHEN
Assistant Professor, Department of Computer Science and Engineering
Director of SMART (Scalable Medical Analysis, Reasoning and Treatment) Lab Associate Director, Research Center of Medical Imaging and Analysis,
The Hong Kong University of Science and Technology

Mr. Vincent CHEUNG
Managing Director and Chief Operating Officer of Nan Fung Group
Chairman of Nan Fung Life Sciences, Nan Fung

Dr Ricky CHIU
Chairman & Chief Executive Officer,
Phase Scientific International Limited, Hong Kong

Mr. Shan FU
Managing Partner, Co-CEO and CEO of Greater China, Vivo Capital

Ms. Vanessa HUANG
General Partner, BVCF

Mr. Wayne HUANG
Chairman and CEO
Hillwoods Capital Management Limited

Mr. Emmanuel HUI
Principal, Sagamore Investment Management

Dr. Patrick LAM
Vice President, IPO Vetting,
Listing Department, Hong Kong Exchanges and Clearing Limited

Mr. Colin LAW
Partner, Fangda Partners

Ms. Lily LI
Managing Director, Shenzhen Capital Group

Mr. Da LIU
Managing Director, China Resources (CR-CP Life Science Fund)

Chief Executive Officer, Hong Kong Genome Institute

Mr. Stanley SY
Chief Clinical Development Officer,
ACT Genomics Co.

Prof. Lap Chee TSUI
Founding President, Hong Kong Academy of Sciences
President, Victor and William Fung Foundation (HK)
HKAS, Victor and William Fung Foundation

Mr. Albert WONG
Chief Executive Officer, HKSTPC

Contact Us